Stock listing
Lumos Diagnostics Holdings Ltd.
Selected listing: LDX · ASX · AUD · AU
Lumos Diagnostics Holdings Ltd. (ASX:LDX), Health Technology. Latest release Sep 14, 2026: FebriDx Commercial Traction Continues Across US Accounts.
- Ticker
- ASX:LDX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
About Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics Holdings Ltd. (LDX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Lumos Diagnostics Holdings Ltd.
FebriDx Commercial Traction Continues Across US Accounts
September 14, 2026
FY26 Full Year Results Announcement
August 25, 2026
Lumos Receives FebriDx Order from PHASE Scientific
August 3, 2026
FebriDx Commercial Traction Across Priority US Accounts
July 20, 2026
FebriDx U.S. Rollout and Reimbursement Update - Amended
May 18, 2026
Events
Replays
Research Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics Holdings Ltd. company profile
View the public company page for Lumos Diagnostics Holdings Ltd. on 6ix.
Lumos Diagnostics Holdings Ltd. news
Read company news and market updates connected to Lumos Diagnostics Holdings Ltd..
Lumos Diagnostics Holdings Ltd. investor events
Find investor webinars, events, and replay context for Lumos Diagnostics Holdings Ltd..